Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the fourth quarter, ...

While popular drugs like Ozempic and Wegovy are only available as injections, drugmaker Novo Nordisk is working on a more ...

Danish pharmaceutical behemoth Novo Nordisk reported better-than-expected net profit in the fourth quarter, amid soaring ...

Weight-loss jabs, such as Ozempic, Wegovy and Mounjaro, have quickly earned a glowing global reputation for shifting the ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Novo Nordisk is under pressure from investors for more information about its next-generation obesity drug candidate CagriSema ...

Denmark may curb exports of weight loss drugs Ozempic and Wegovy, as well as Lego, if Trump plans to buy Greenland. Tariffs ...

The late-stage trial of semaglutide, which it markets as Wegovy to treat obesity, showed that those who took a once-weekly dose of 7.2 milligrams lost an average of 20.7% of their weight over 72 ...

Canadian public and private insurers have balked at covering certain medication for weight-loss, but that might change as the drugs are approved for other chronic conditions ...

Lana Hart, 29, has given a brutally honest account about why she turned to weight loss injection Mounjaro amid a national ...